Kim Smith-Whitley
Director Técnico/Científico/I+D en GLOBAL BLOOD THERAPEUTICS, INC. .
Perfil
Kim Smith-Whitley is currently the Director at the Sickle Cell Disease Association of America, Inc. and the Executive VP, Head-Research & Development at Global Blood Therapeutics, Inc. Dr. Smith-Whitley holds a doctorate degree from George Washington University.
Cargos activos de Kim Smith-Whitley
Empresas | Cargo | Inicio |
---|---|---|
GLOBAL BLOOD THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/05/2021 |
Sickle Cell Disease Association of America, Inc. | Director/Miembro de la Junta | - |
Formación de Kim Smith-Whitley.
George Washington University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Sickle Cell Disease Association of America, Inc. |
- Bolsa de valores
- Insiders
- Kim Smith-Whitley